Literature DB >> 18673055

Removal of ossified ligamentum flavum via a minimally invasive surgical approach.

Vincent Y Wang1, Adam S Kanter, Praveen V Mummaneni.   

Abstract

Ossified ligamentum flavum (OLF) in the thoracic spine is a rare cause of myelopathy, often presenting with progressive symptomatology over an extended period of time. Surgical decompression via wide laminectomy has been the mainstay of treatment for this symptomatic disease phenomenon, but complications such as kyphotic deformity have developed due to extensive bone removal and release of the posterior tension band. The authors present a case of OLF excised via a minimally invasive microsurgical approach in which an expandable tubular retractor system was used. This approach enables complete decompression of the spinal canal while minimizing nerve, vascular, and musculoskeletal disruption, thus maintaining the native biomechanical disposition of the intact vertebral column.

Entities:  

Mesh:

Year:  2008        PMID: 18673055     DOI: 10.3171/FOC/2008/25/8/E7

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  3 in total

1.  Treatment strategies for the surgical complications of thoracic spinal stenosis: a retrospective analysis of two hundred and eighty three cases.

Authors:  Baorong He; Liang Yan; Zhengwei Xu; Hua Guo; Tuanjiang Liu; Dingjun Hao
Journal:  Int Orthop       Date:  2013-09-22       Impact factor: 3.075

2.  Microendoscopic posterior decompression for the treatment of thoracic myelopathy caused by ossification of the ligamentum flavum: a technical report.

Authors:  Satoshi Baba; Yasushi Oshima; Tomoyuki Iwahori; Yuichi Takano; Hirohiko Inanami; Hisashi Koga
Journal:  Eur Spine J       Date:  2015-07-30       Impact factor: 3.134

3.  Bilateral translaminar osseous-channel assisted percutaneous full-endoscopic ligamentectomy decompression for thoracic myelopathy due to ossification of the ligamentum flavum: a technical note.

Authors:  Zhijun Xin; Weijun Kong; Qian Du; Wenbo Liao
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2020-11-15       Impact factor: 1.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.